NASDAQ:TRHC - Tabula Rasa HealthCare Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $60.57 +0.26 (+0.43 %) (As of 03/20/2019 11:13 AM ET)Previous Close$60.31Today's Range$60.45 - $61.0652-Week Range$35.08 - $91.16Volume1,121 shsAverage Volume514,670 shsMarket Capitalization$1.28 billionP/E Ratio178.15Dividend YieldN/ABeta1.66 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey. Receive TRHC News and Ratings via Email Sign-up to receive the latest news and ratings for TRHC and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Business services, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:TRHC Previous Symbol CUSIPN/A CIK1651561 Webwww.tabularasahealthcare.com Phone866-648-2767Debt Debt-to-Equity Ratio0.32 Current Ratio0.84 Quick Ratio0.79Price-To-Earnings Trailing P/E Ratio178.15 Forward P/E Ratio-673.00 P/E GrowthN/A Sales & Book Value Annual Sales$204.27 million Price / Sales6.27 Cash Flow$1.2882 per share Price / Cash Flow47.02 Book Value$6.79 per share Price / Book8.92Profitability EPS (Most Recent Fiscal Year)$0.34 Net Income$-47,270,000.00 Net Margins-23.14% Return on Equity7.76% Return on Assets3.69%Miscellaneous EmployeesN/A Outstanding Shares21,130,000Market Cap$1.28 billion Next Earnings Date5/14/2019 (Estimated) OptionableOptionable Tabula Rasa HealthCare (NASDAQ:TRHC) Frequently Asked Questions What is Tabula Rasa HealthCare's stock symbol? Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC." How were Tabula Rasa HealthCare's earnings last quarter? Tabula Rasa HealthCare Inc (NASDAQ:TRHC) released its quarterly earnings results on Tuesday, August, 7th. The company reported $0.20 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.08 by $0.12. The business had revenue of $48.60 million for the quarter, compared to the consensus estimate of $46.73 million. Tabula Rasa HealthCare had a negative net margin of 23.14% and a positive return on equity of 7.76%. View Tabula Rasa HealthCare's Earnings History. When is Tabula Rasa HealthCare's next earnings date? Tabula Rasa HealthCare is scheduled to release their next quarterly earnings announcement on Tuesday, May 14th 2019. View Earnings Estimates for Tabula Rasa HealthCare. What guidance has Tabula Rasa HealthCare issued on next quarter's earnings? Tabula Rasa HealthCare updated its FY 2019 earnings guidance on Thursday, February, 28th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $250-260 million, compared to the consensus revenue estimate of $251.9 million.Tabula Rasa HealthCare also updated its Q1 2019 guidance to EPS. What price target have analysts set for TRHC? 9 equities research analysts have issued 12 month price targets for Tabula Rasa HealthCare's stock. Their forecasts range from $58.33 to $100.00. On average, they anticipate Tabula Rasa HealthCare's stock price to reach $87.37 in the next year. This suggests a possible upside of 44.1% from the stock's current price. View Analyst Price Targets for Tabula Rasa HealthCare. What is the consensus analysts' recommendation for Tabula Rasa HealthCare? 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last year. There are currently 1 hold rating, 7 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Tabula Rasa HealthCare. What are Wall Street analysts saying about Tabula Rasa HealthCare stock? Here are some recent quotes from research analysts about Tabula Rasa HealthCare stock: 1. Cantor Fitzgerald analysts commented, ". We reiterate our Overweight rating and $99 12-month price target on TRHC shares. Rasa reported solid 4Q18 results, which were generally above FactSet consensus estimates. The company’s profitability was affected by a shift in mix due to recently acquired businesses and investments related to TRHC 2.0. That said, the company is confident these investments will pay dividends and margins will expand over time. TRHC provided 2019 guidance, noting that the adjusted EBITDA outlook was slightly below expectations, due to continued investments in the TRHC 2.0 initiatives." (2/28/2019) 2. According to Zacks Investment Research, "Tabula Rasa HealthCare, Inc. is a provider of patient-specific, data-driven technology and solutions which enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. The company's cloud-based software applications including EireneRx and MedWise Advisor which provide solutions to payers, providers and other healthcare organizations. Tabula Rasa HealthCare, Inc. is based in NJ, United States. " (1/22/2019) Has Tabula Rasa HealthCare been receiving favorable news coverage? News stories about TRHC stock have been trending somewhat positive on Wednesday, according to InfoTrie Sentiment. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Tabula Rasa HealthCare earned a news impact score of 1.7 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. Are investors shorting Tabula Rasa HealthCare? Tabula Rasa HealthCare saw a increase in short interest in February. As of February 15th, there was short interest totalling 2,618,861 shares, an increase of 52.5% from the January 31st total of 1,716,946 shares. Based on an average daily trading volume, of 604,671 shares, the days-to-cover ratio is currently 4.3 days. Currently, 14.8% of the shares of the stock are sold short. View Tabula Rasa HealthCare's Current Options Chain. Who are some of Tabula Rasa HealthCare's key competitors? Some companies that are related to Tabula Rasa HealthCare include MAXIMUS (MMS), TriNet Group (TNET), Ritchie Bros. Auctioneers (RBA), Envestnet (ENV), Conduent (CNDT), HMS (HMSY), WNS (WNS), GreenSky (GSKY), EVO Payments (EVOP), ExlService (EXLS), Sothebys (BID), Wageworks (WAGE), Stamps.com (STMP), Cardtronics (CATM) and COMSCORE (SCOR). What other stocks do shareholders of Tabula Rasa HealthCare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Micron Technology (MU), Netflix (NFLX), Adobe (ADBE), QUALCOMM (QCOM), Alibaba Group (BABA), Align Technology (ALGN), TENCENT HOLDING/ADR (TCEHY), Advanced Micro Devices (AMD) and Workday (WDAY). Who are Tabula Rasa HealthCare's key executives? Tabula Rasa HealthCare's management team includes the folowing people: Dr. Calvin H. Knowlton, Co-Founder, Chairman & CEO (Age 69)Dr. Orsula V. Knowlton BScPharm, PharmD, MBA, Co-Founder, Pres, Chief Marketing & New Bus. Devel. Officer and Director (Age 50)Mr. Brian W. Adams, CFO & Sec. (Age 37)Mr. Michael Greenhalgh BScPharm, RPh, Chief Operating OfficerMs. Andrea Carolan Speers, Corp. Controller & Chief Accounting Officer (Age 37) When did Tabula Rasa HealthCare IPO? (TRHC) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,300,000 shares at $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray acted as the underwriters for the IPO and Baird and Stifel were co-managers. Who are Tabula Rasa HealthCare's major shareholders? Tabula Rasa HealthCare's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (12.71%), Jennison Associates LLC (3.69%), M&T Bank Corp (2.59%), Ranger Investment Management L.P. (2.32%), Macquarie Group Ltd. (1.54%) and Bank of New York Mellon Corp (1.37%). Company insiders that own Tabula Rasa HealthCare stock include Andrea Carolan Speers, Brian W Adams, Bruce Luehrs, Calvin H Knowlton, Glen R Bressner, Gordon Tunstall, Growth Fund 1Q Lp Originate, Orsula V Knowlton and Samira Beckwith. View Institutional Ownership Trends for Tabula Rasa HealthCare. Which major investors are selling Tabula Rasa HealthCare stock? TRHC stock was sold by a variety of institutional investors in the last quarter, including Timpani Capital Management LLC, Voloridge Investment Management LLC, Barclays PLC, Granite Investment Partners LLC, Tygh Capital Management Inc., Gemmer Asset Management LLC, Intrinsic Edge Capital Management LLC and Eagle Asset Management Inc.. Company insiders that have sold Tabula Rasa HealthCare company stock in the last year include Andrea Carolan Speers, Brian W Adams, Bruce Luehrs, Calvin H Knowlton, Gordon Tunstall, Orsula V Knowlton and Samira Beckwith. View Insider Buying and Selling for Tabula Rasa HealthCare. Which major investors are buying Tabula Rasa HealthCare stock? TRHC stock was bought by a variety of institutional investors in the last quarter, including M&T Bank Corp, Macquarie Group Ltd., Polar Capital LLP, First Trust Advisors LP, BlackRock Inc., New York State Common Retirement Fund, Fiera Capital Corp and SG Americas Securities LLC. Company insiders that have bought Tabula Rasa HealthCare stock in the last two years include Brian W Adams, Glen R Bressner and Orsula V Knowlton. View Insider Buying and Selling for Tabula Rasa HealthCare. How do I buy shares of Tabula Rasa HealthCare? Shares of TRHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Tabula Rasa HealthCare's stock price today? One share of TRHC stock can currently be purchased for approximately $60.6450. How big of a company is Tabula Rasa HealthCare? Tabula Rasa HealthCare has a market capitalization of $1.28 billion and generates $204.27 million in revenue each year. The company earns $-47,270,000.00 in net income (profit) each year or $0.34 on an earnings per share basis. What is Tabula Rasa HealthCare's official website? The official website for Tabula Rasa HealthCare is http://www.tabularasahealthcare.com. How can I contact Tabula Rasa HealthCare? Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The company can be reached via phone at 866-648-2767 or via email at [email protected] MarketBeat Community Rating for Tabula Rasa HealthCare (NASDAQ TRHC)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 223 (Vote Outperform)Underperform Votes: 196 (Vote Underperform)Total Votes: 419MarketBeat's community ratings are surveys of what our community members think about Tabula Rasa HealthCare and other stocks. Vote "Outperform" if you believe TRHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRHC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/20/2019 by MarketBeat.com StaffFeatured Article: What is insider trading?